| | |
AIMed
|
BioInfer
|
HPRD50
|
IEPA
|
LLL
|
|---|
| |
size
|
1955
|
1100
|
145
|
486
|
77
|
|
Entity
|
scope
|
human P/G
|
P/G/R and related
|
human P/G
|
Chemicals
|
P/G
|
|
coverage
|
all occurrences
|
all occurrences
|
NER system
|
list of 16 names
|
list of 116 names
| |
|
types
|
no
|
111 types (ontology)
|
no
|
no
|
P/G
| |
|
PPI
|
types
|
no
|
68 types (ontology)
|
no
|
no
|
3 types
|
|
binding
|
no
|
yes
|
no
|
yes
|
no
| |
|
directed
|
no
|
yes
|
no
|
yes
|
yes
| |
|
complex
|
no
|
yes
|
no
|
no
|
no
| |
|
negative
|
no
|
yes
|
no
|
no
|
no
| |
|
certainty
|
no
|
no
|
yes
|
no
|
no
| |
- Legend:
- Size: Number of sentences in the corpus
- Entity scope: Types of the named entities identified in the corpus: (P)rotein, (G)ene, (R)NA
- Entity coverage: Coverage of in-scope entity occurrences in each sentence
- Entity types: Explicit identification of the type of the annotated named entity occurrences
- PPI types: Explicit indication of the type of the annotated interactions
- PPI binding: Identification of the specific text spans that entail the annotated interactions
- PPI directed: Specification of the directionality of the interaction (typically identification of agent vs. patient roles)
- PPI complex: Annotation includes nested or n-ary (for n > 2) interactions
- PPI negative: Annotation of negative interactions
- PPI certainty: Annotation of the levels of certainty, or speculativeness, of interactions
